Morgan Stanley »

Sage Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2023-09-30 $18M 864k 20.58
2023-06-30 $17M 352k 47.02
2022-12-31 $19M 504k 38.20
2022-06-30 $17M 573k 30.00
2022-03-31 $19M 565k 33.03
2021-06-30 $33M 578k 56.89
2020-12-31 $14M 159k 86.44
2020-09-30 $16M 266k 61.16
2020-06-30 $6.3M 153k 41.58
2020-03-31 $29M 993k 28.72
2019-12-31 $6.1M 84k 72.26
2019-09-30 $8.9M 63k 140.26
2019-03-31 $13M 82k 159.39
2018-12-31 $8.3M 87k 95.77
2018-09-30 $13M 95k 141.25
2018-06-30 $19M 121k 156.54
2018-03-31 $26M 159k 161.07
2017-12-31 $32M 193k 164.71
2017-03-31 $3.5M 49k 71.06
2016-12-31 $5.0M 98k 51.06
2016-09-30 $1.0M 22k 47.62
2016-06-30 $2.2M 72k 30.13
2016-03-31 $303k 9.5k 31.90
2015-12-31 $438k 7.6k 58.02
2015-09-30 $365k 8.4k 43.22
2015-06-30 $1.4M 19k 73.00
2014-12-31 $72k 2.0k 36.72
2014-09-30 $58k 1.8k 31.44